Phase 2 Endometrial Cancer Trial, Recruiting NCT07003620 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Endometrial Cancer
Back to Endometrial Cancer

Phase 2 Endometrial Cancer Trial, Recruiting

NCT07003620
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People diagnosed with locally advanced cervical cancer at a specific stage (FIGO stages IB3 to IIB) with a primary tumour larger than 4 cm.
  • People whose cervical cancer has been confirmed through a tissue sample (biopsy) as one of three specific types: squamous cell carcinoma, adenosquamous carcinoma, or common adenocarcinoma.
  • People who are generally well enough to carry out daily activities with little to no limitation (confirm with trial site for exact fitness level required).
  • People who have not yet received any treatment for their condition.

Who may not be able to join:

  • People who have had a different type of cancer at any point in the past.
  • People whose medical records or treatment details are incomplete.
  • People who have other serious health conditions, or who may not be able to attend all required follow-up appointments.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 18688395806

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Registry
ClinicalTrials.gov
Start date
29 June 2025
Est. completion
30 October 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Objective response rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov